States across the U.S. have taken on high drug prices with new laws, proposals and Medicaid rules, many of them unpopular with the pharma industry. Not so in Louisiana, where a “Netflix” payment model for hepatitis C drugs has top players eager to partici
As drug costs continue to capture national attention and the Trump Administration tries its hand at providing relief, Louisiana has rolled out a proposal it thinks can help solve the state afford the high cost of hepatitis C drugs.